Sepsis - Nursing Case Study

Pathophysiology

• Primary mechanism: Dysregulated Host Response - Sepsis begins with an overwhelming immune response to an infection, where pro-inflammatory mediators are released excessively, leading to widespread inflammation and tissue damage rather than localized infection control.

• Secondary mechanism: Endothelial Dysfunction - The inflammatory response damages endothelial cells lining blood vessels, increasing vascular permeability. This results in fluid leakage into tissues, causing edema and impaired organ perfusion.

• Key complication: Multiple Organ Dysfunction Syndrome (MODS) - The combined effects of systemic inflammation and endothelial dysfunction can lead to insufficient oxygen and nutrient delivery to vital organs, progressing to organ failure if not promptly managed.

Patient Profile

Demographics:

62-year-old female, retired school teacher

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Chronic Kidney Disease Stage 3

• Current medications: Lisinopril, Metformin, Insulin Glargine, Amlodipine

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Shortness of breath and confusion

• Key symptoms: Fever, chills, productive cough with purulent sputum, increasing fatigue, decreased urine output

• Vital signs: Temperature 38.9°C (102°F), Heart Rate 112 bpm, Respiratory Rate 24 breaths per minute, Blood Pressure 88/56 mmHg, Oxygen Saturation 89% on room air

Section 1

As the healthcare team continues to assess the patient, new diagnostic results reveal a significant elevation in lactate levels at 4.5 mmol/L, indicating impaired tissue oxygenation and a progression towards septic shock. Blood cultures return positive for Streptococcus pneumoniae, confirming a bacterial source for the infection. The complete blood count shows leukocytosis with a white blood cell count of 18,000/mm³ and a marked left shift, suggesting an acute inflammatory response. Additionally, renal function has deteriorated further, with serum creatinine rising from baseline at 1.8 mg/dL to 3.2 mg/dL, reflecting worsening kidney function and highlighting the impact of both sepsis and chronic kidney disease on her renal system.

In light of these findings, the medical team initiates a broad-spectrum antibiotic regimen tailored to the patient's penicillin allergy, opting for a combination of ceftriaxone and azithromycin to effectively target the identified pathogen. Simultaneously, aggressive fluid resuscitation with crystalloids is commenced to address hypotension and support organ perfusion. Despite these interventions, the patient's condition remains tenuous; her blood pressure stabilizes only marginally at 92/58 mmHg with ongoing tachycardia. Oxygen therapy is escalated to high-flow nasal cannula, improving her oxygen saturation to 94%, yet her mental status shows minimal improvement, with persistent confusion and lethargy.

As the patient's clinical status evolves, the team must consider the risk of further complications, such as acute respiratory distress syndrome (ARDS) and disseminated intravascular coagulation (DIC), both potential sequelae of severe sepsis. Careful monitoring of coagulation profiles and respiratory function becomes paramount, alongside continued evaluation of her hemodynamic stability and organ function. The interdisciplinary team's focus remains on preventing progression to MODS by optimizing supportive care and timely adjusting therapeutic strategies, emphasizing the need for vigilant reassessment and collaborative clinical reasoning to guide the next steps in her management.

Section 2

As the patient's treatment continues, the healthcare team notes a change in her status, indicating a potential development of new complications. Despite aggressive fluid resuscitation and antibiotic therapy, the patient's urine output has decreased significantly to 20 mL over the past hour, suggesting worsening renal perfusion. Her respiratory status is also showing signs of decline; she is now exhibiting increased work of breathing with a respiratory rate climbing to 32 breaths per minute, and her oxygen saturation has dropped to 89% despite high-flow nasal cannula support. Additionally, her skin appears cool and mottled, particularly on the extremities, raising concerns for peripheral hypoperfusion.

Given these developments, the team orders a chest X-ray and arterial blood gas analysis to further assess her respiratory function. The chest X-ray reveals bilateral infiltrates consistent with pulmonary edema, raising the suspicion of acute respiratory distress syndrome (ARDS). The arterial blood gas results show a pH of 7.32, PaCO2 of 48 mmHg, and PaO2 of 55 mmHg, indicating a mixed respiratory and metabolic acidosis. These findings suggest that despite ongoing treatment, the patient is progressing towards respiratory failure, potentially requiring escalation to invasive mechanical ventilation.

The clinical team must now prioritize stabilizing the patient's respiratory status while continuing to address her hemodynamic instability. The decision is made to transfer the patient to the intensive care unit for closer monitoring and potential intubation and mechanical ventilation. The complexity of her condition necessitates frequent reassessment and a multidisciplinary approach to optimize her care. Attention will remain on balancing fluid management to support perfusion without exacerbating pulmonary edema, and further refining antibiotic therapy based on culture sensitivities. The team's collaborative efforts will focus on preventing further deterioration and managing her evolving multi-organ dysfunction.

Section 3

In the intensive care unit, the initial focus is on stabilizing the patient's respiratory status. The decision to intubate and initiate mechanical ventilation is made due to her continual respiratory distress and deteriorating blood gas results. Post-intubation, the ventilator is set to assist-control mode with a tidal volume of 6 mL/kg and a positive end-expiratory pressure (PEEP) of 10 cm H2O to address her ARDS and improve oxygenation. Her oxygen saturation improves to 92%, but her blood pressure begins to trend downward, now reading 85/50 mmHg, suggesting ongoing hemodynamic instability.

Given her decreased urine output and hypotension, a central venous catheter is placed to allow for more precise hemodynamic monitoring and administration of vasopressors. A norepinephrine infusion is started at 0.05 mcg/kg/min to support her blood pressure. Meanwhile, the medical team reviews her latest laboratory results, which reveal a rising creatinine level of 3.2 mg/dL from a baseline of 1.0 mg/dL, indicating worsening acute kidney injury. The patient's lactate level is also elevated at 4.5 mmol/L, reflecting persistent tissue hypoperfusion.

While the mechanical ventilation and vasopressor support help stabilize her vital signs, clinicians remain vigilant for further complications, particularly given the rising creatinine and lactate levels. Plans are made for continuous renal replacement therapy (CRRT) to manage her renal failure while minimizing fluid overload. The team also re-evaluates her antibiotic regimen, considering the culture results that show sensitivity to a narrower spectrum antibiotic, which is then adjusted accordingly. The patient's condition is monitored closely for any signs of improvement or further decline, ready to adapt the treatment plan as needed in this complex and dynamic situation.

Section 4

As the medical team continues to monitor the patient's status, they observe new developments in her clinical condition that require immediate attention. Despite the initial stabilization from mechanical ventilation and vasopressor support, her respiratory status begins to show signs of decline. The team notices an increase in peak airway pressures on the ventilator, indicating worsening lung compliance. A repeat chest X-ray is ordered, revealing bilateral pulmonary infiltrates have increased, suggesting progression of acute respiratory distress syndrome (ARDS) and potential development of pneumonia.

Concurrently, the patient's hemodynamic status remains fragile. Although the norepinephrine infusion has been titrated to 0.1 mcg/kg/min to maintain her mean arterial pressure above 65 mmHg, she develops a new fever of 38.9°C. Her heart rate has increased to 120 bpm, and there is a newly detected systolic murmur at the left sternal border. Blood cultures are re-drawn to assess for any secondary infections or complications such as infective endocarditis, which could be contributing to her hemodynamic instability and fever.

As the team evaluates these findings, they note the potential need to escalate antibiotic therapy if a new infectious source is confirmed. The patient's elevated lactate, persisting at 4.8 mmol/L, further emphasizes the ongoing tissue hypoperfusion and metabolic stress. The decision is made to initiate CRRT as planned, aiming to manage her acute kidney injury and remove cytokines that may be contributing to her systemic inflammatory response. The multidisciplinary team remains on high alert, ready to make further adjustments to her treatment plan based on the evolving clinical picture.

Section 5

As the multidisciplinary team continues to monitor the patient, they observe a change in her status that warrants immediate attention. Despite the initiation of continuous renal replacement therapy (CRRT), her urine output remains minimal, and her creatinine level has climbed to 3.2 mg/dL, indicating a worsening of her acute kidney injury. Additionally, the team notes a decline in her mental status; the patient is now lethargic and difficult to arouse, suggesting potential metabolic encephalopathy secondary to her renal failure and persistent sepsis.

Laboratory results reveal a further drop in her platelet count to 80,000/mm³, raising concerns for disseminated intravascular coagulation (DIC) as a complication of her severe sepsis. Her coagulation profile shows a prolonged prothrombin time (PT) of 17 seconds and an elevated D-dimer level, supporting the suspicion of DIC. The team discusses the need for careful monitoring of her coagulation status and considers the potential need for transfusion of platelets or fresh frozen plasma depending on her clinical stability and bleeding risk.

Given these developments, the team decides to broaden the patient's antibiotic coverage empirically, pending blood culture results, to address the possible development of pneumonia and any other secondary infections. Additionally, they contemplate the introduction of low-dose hydrocortisone therapy to potentially stabilize her hemodynamic status and address refractory septic shock. The team remains vigilant, recognizing the urgency of addressing these complications while continuing to support her respiratory and renal functions, understanding that her condition remains precarious and requires ongoing, dynamic management.